Bridgebio Oncology Therapeutics Inc (BBOT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 49,181 | 0 | 19,664 |
| Operating Income | -49,181 | N/A | -19,664 |
| Other Income | 4,424 | 0 | 2,341 |
| Pre-tax Income | -44,757 | 0 | -17,323 |
| Net Income Continuous | -44,757 | N/A | -17,323 |
| Net Income | $-44,757 | $N/A | $-17,323 |
| EPS Basic Total Ops | -1.03 | N/A | -1,562.18 |
| EPS Basic Continuous Ops | -1.03 | N/A | -1,562.18 |
| EPS Diluted Total Ops | -1.03 | N/A | -1,562.18 |
| EPS Diluted Continuous Ops | -1.03 | N/A | -1,562.18 |
| EPS Diluted Before Non-Recurring Items | -1.03 | N/A | N/A |
| EBITDA(a) | $-49,181 | $N/A | $-19,664 |